Journal article
Disseminate and Recurrent Infundibulofolliculitis: An Under-Recognized Yet Treatable Entity
JOURNAL OF DRUGS IN DERMATOLOGY, v 20(12), pp 1353-1354
Dec 2021
PMID: 34898159
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Disseminate and recurrent infundibulofolliculitis (DRIF) is a pruritic papular eruption that predominantly affects young adults with Fitzpatrick skin types 4-6. Due to DRIF's rarity and under-recognition, no standardized treatment guidelines exist. However, several oral agents have been used, including vitamin A, antibiotics, and retinoids. Topical agents, such as calcineurin inhibitors and mid-potency steroids, can also be efficacious. This brief communication summarizes treatments for DRIF in the published literature.
Metrics
Details
- Title
- Disseminate and Recurrent Infundibulofolliculitis: An Under-Recognized Yet Treatable Entity
- Publication Details
- JOURNAL OF DRUGS IN DERMATOLOGY, v 20(12), pp 1353-1354
- Publisher
- JOURNAL OF DRUGS IN DERMATOLOGY; NEW YORK
- Number of pages
- 1
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Drexel University
- Web of Science ID
- WOS:000732026900014
- Scopus ID
- 2-s2.0-85122775056
- Other Identifier
- 991021860763304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Dermatology